These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 21847881

  • 1. Commercial speech and off-label drug uses: what role for wide acceptance, general recognition and research incentives?
    Gilhooley M.
    Am J Law Med; 2011; 37(2-3):258-77. PubMed ID: 21847881
    [Abstract] [Full Text] [Related]

  • 2. Truth, Falsity, and Fraud: Off-Label Drug Settlements and the Future of the Civil False Claims Act.
    Krause JH.
    Food Drug Law J; 2016; 71(3):401-40. PubMed ID: 29140064
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pharmaceutical Industry Off-label Promotion and Self-regulation: A Document Analysis of Off-label Promotion Rulings by the United Kingdom Prescription Medicines Code of Practice Authority 2003-2012.
    Vilhelmsson A, Davis C, Mulinari S.
    PLoS Med; 2016 Jan; 13(1):e1001945. PubMed ID: 26812151
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Off-label marketing and the First Amendment.
    Boumil MM.
    N Engl J Med; 2013 Jan 10; 368(2):103-5. PubMed ID: 23234470
    [No Abstract] [Full Text] [Related]

  • 10. Court rules that FDA cannot restrict off-label marketing.
    Roehr B.
    BMJ; 2015 Aug 11; 351():h4367. PubMed ID: 26265632
    [No Abstract] [Full Text] [Related]

  • 11. Recent case developments in health law. False Claims Act: the right treatment for off-label marketing?
    Wang S.
    J Law Med Ethics; 2010 Aug 11; 38(3):708-13. PubMed ID: 20880253
    [No Abstract] [Full Text] [Related]

  • 12. United States v. Caronia: Off-Label Drug Promotion and First Amendment Balancing.
    Rabinowitz DP.
    Fordham Law Rev; 2018 Apr 11; 86(5):2595-623. PubMed ID: 29993225
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Free speech rights outweigh restrictions on promoting drugs off label, court rules.
    Roehr B.
    BMJ; 2012 Dec 06; 345():e8324. PubMed ID: 23220261
    [No Abstract] [Full Text] [Related]

  • 16. Off-label marketing: free speech or illegal promotion?
    Silverman E.
    BMJ; 2013 Jan 22; 346():f320. PubMed ID: 23341546
    [No Abstract] [Full Text] [Related]

  • 17. Off-label use of medical products in radiation therapy: summary of the report of AAPM Task Group No. 121.
    Thomadsen BR, Heaton HT, Jani SK, Masten JP, Napolitano ME, Ouhib Z, Reft CS, Rivard MJ, Robin TT, Subramanian M, Suleiman OH.
    Med Phys; 2010 May 22; 37(5):2300-11. PubMed ID: 20527564
    [Abstract] [Full Text] [Related]

  • 18. Preemption of the "fraud on the FDA" exception to Michigan's tort immunity statute for drug manufacturers: reconsidering Garcia and Desiano after Levine.
    Murdey J.
    Food Drug Law J; 2011 May 22; 66(1):85-104, ii-iii. PubMed ID: 24505848
    [Abstract] [Full Text] [Related]

  • 19. Investigating pharmaceutical marketing in Canada using American prosecutions.
    Shoucri R, Persaud N.
    Int J Risk Saf Med; 2014 May 22; 26(3):147-53. PubMed ID: 25214160
    [Abstract] [Full Text] [Related]

  • 20. Off-label or out of bounds? Prescriber and marketer liability for unapproved uses of FDA-approved drugs.
    O'Reilly J, Dalal A.
    Ann Health Law; 2003 May 22; 12(2):295-324, table of contents. PubMed ID: 12856461
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.